TÜRK, M. Et Al. 2018. Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients. EAACI Annual Congress 2018 , (Munich, Germany).

TÜRK, M., NAZİK BAHÇECİOĞLU, S., TUTAR, N., OYMAK, F. S., GÜLMEZ, İ., & YURDAKUL, A. S., (2018). Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients . EAACI Annual Congress 2018, Munich, Germany

TÜRK, MURAT Et Al. "Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients," EAACI Annual Congress 2018, Munich, Germany, 2018

TÜRK, MURAT Et Al. "Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients." EAACI Annual Congress 2018 , Munich, Germany, 2018

TÜRK, M. Et Al. (2018) . "Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients." EAACI Annual Congress 2018 , Munich, Germany.

@conferencepaper{conferencepaper, author={MURAT TÜRK Et Al. }, title={Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients}, congress name={EAACI Annual Congress 2018}, city={Munich}, country={Germany}, year={2018}}